You have 9 free searches left this month | for more free features.

meningeal

Showing 26 - 50 of 391

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Biomechanical Coupling of Brain and Skull

Recruiting
  • Traumatic Brain Injury (Tbi)
  • Traumatic Meningeal Enhancement (Tme)
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Feb 2, 2023

    Tuberculous Meningitis, Tuberculous Arachnoiditis Trial in New Delhi (MRI Brain and spine, Reference standard diagnostic

    Recruiting
    • Tuberculous Meningitis
    • Tuberculous Arachnoiditis
    • MRI Brain and spine
    • Reference standard diagnostic criteria
    • New Delhi, Delhi, India
      All India Institute of Medical Sciences, New Delhi
    Nov 23, 2022

    Chronic Subdural Hematoma Trial in Winnipeg (Embolization of the Middle Meningeal Artery)

    Recruiting
    • Chronic Subdural Hematoma
    • Embolization of the Middle Meningeal Artery
    • Winnipeg, Manitoba, Canada
      University of Manitoba
    Sep 13, 2021

    Breast Cancer Female, Leptomeningeal Metastases Trial in Charlottesville (HER2 BATs)

    Terminated
    • Breast Cancer Female
    • Leptomeningeal Metastases
    • HER2 BATs
    • Charlottesville, Virginia
      University of Virginia
    Dec 15, 2022

    Tuberculosis, Extrapulmonary Trial in South Africa, Zambia, Zimbabwe (IRISA-TB)

    Recruiting
    • Tuberculosis, Extrapulmonary
    • IRISA-TB
    • Durban, KwaZulu-Natal, South Africa
    • +3 more
    Nov 13, 2023

    Leptomeningeal Metastases, Leptomeningeal Disease Trial in Tampa (Avelumab, Whole Brain Radiotherapy)

    Active, not recruiting
    • Leptomeningeal Metastases
    • Leptomeningeal Disease
    • Tampa, Florida
      H. Lee Moffitt Cancer Center and Research Institute
    Aug 19, 2022

    HER2-positive Breast Cancer, Leptomeningeal Metastasis, Leptomeningeal Disease Trial in Tampa, Evanston (Radiation Therapy,

    Recruiting
    • HER2-positive Breast Cancer
    • +2 more
    • Radiation Therapy
    • +2 more
    • Tampa, Florida
    • +1 more
    Dec 30, 2022

    Tuberculous Meningitis, HIV I Infection Trial in Rio De Janeiro, Maputo, Lusaka (Adalimumab Injection)

    Not yet recruiting
    • Tuberculous Meningitis
    • HIV I Infection
    • Adalimumab Injection
    • Rio De Janeiro, Brazil
    • +2 more
    Jan 31, 2023

    Leptomeningeal Disease, Triple Negative Breast Cancer, HER2-positive Breast Cancer Trial in Tampa (Dendritic Cell Vaccine)

    Recruiting
    • Leptomeningeal Disease
    • +2 more
    • Dendritic Cell Vaccine
    • Tampa, Florida
      Moffitt Cancer Center
    Apr 11, 2023

    based Approaches for Improving Diagnosis of Childhood

    Recruiting
    • Tuberculous Meningitis
      • Cape Town, Western Cape, South Africa
        Stellenbosch University Immunology Research Group
      May 16, 2022

      Tuberculous Meningitis Trial in Chennai (High dose rifampicin (25mg/kg), Moxifloxacin 400mg, Aspirin 150 mg)

      Not yet recruiting
      • Tuberculous Meningitis
      • High dose rifampicin (25mg/kg)
      • +8 more
      • Chennai, Tamil Nadu, India
        ICMR- National Institute for Research in Tuberculosis
      Jun 15, 2023

      CNS/Leptomeningeal Tumors Trial in New York (131I-omburtamab)

      Available
      • Central Nervous System/Leptomeningeal Neoplasms
      • New York, New York
        Memorial Sloan Kettering Cancer Center
      Jul 15, 2022

      Spina Bifida, Myelomeningocele, Myeloschisis Trial in Houston (NEOX Cord 1K applied fetoscopically)

      Recruiting
      • Spina Bifida
      • +2 more
      • NEOX Cord 1K applied fetoscopically
      • Houston, Texas
        The University of Texas Health Science Center at Houston
      Jun 14, 2022

      Leptomeningeal Metastasis, NSCLC Stage IV, Melanoma Stage IV Trial in Geneva, St Gallen, Zurich (intrathecal nivolumab and

      Recruiting
      • Leptomeningeal Metastasis
      • +2 more
      • intrathecal nivolumab and intrathecal ipilimumab
      • Geneva, Switzerland
      • +2 more
      Dec 18, 2022

      Leptomeningeal Metastasis, Immune Checkpoint Inhibitor, Endostatin Trial in Hebei (Camrelizumab or envafolimab)

      Recruiting
      • Leptomeningeal Metastasis
      • +2 more
      • Camrelizumab or envafolimab
      • Hebei, China
        The Second Hospital of Hebei Medical University
      May 19, 2022

      Chronic Subdural Hematoma Trial in New York (Middel Meningeal Artery Embolization)

      Completed
      • Chronic Subdural Hematoma
      • Middel Meningeal Artery Embolization
      • New York, New York
        Weill Cornell Medical College
      Mar 2, 2021

      Leptomeningeal Metastases Trial in Changchun (Pemetrexed (1), Pemetrexed (2), Folic Acid)

      Recruiting
      • Leptomeningeal Metastases
      • Pemetrexed (1)
      • +4 more
      • Changchun, Jilin, China
        The First Hospital of Jilin University
      Sep 29, 2022

      Leptomeningeal Disease Trial in Germany (Nivolumab [Opdivo])

      Recruiting
      • Leptomeningeal Disease
      • Nivolumab [Opdivo]
      • Freiburg, Germany
      • +6 more
      Nov 2, 2022

      Leptomeningeal Metastasis Trial in Dallas, San Antonio (186RNL)

      Recruiting
      • Leptomeningeal Metastasis
      • Dallas, Texas
      • +1 more
      Jul 12, 2022

      Dalpiciclib Combined With Third-generation EGFR-TKI in EGFR

      Not yet recruiting
      • Non-small Cell Lung Cancer Confirmed by Histopathology or Cytology
      • +6 more
        • (no location specified)
        Aug 9, 2022

        Chronic Subdural Hematoma Trial in Barcelona (Post surgical embolization of middle meningeal artery with liquid embolic agents

        Recruiting
        • Chronic Subdural Hematoma
        • Post surgical embolization of middle meningeal artery with liquid embolic agents (ethylene vinyl alcohol copolymers as Onix, Squid, Phil or Libro)
        • Barcelona, Spain
          Hospital Universitari Vall d'Hebron
        Mar 4, 2022

        Leptomeningeal Metastasis Trial in Changchun (Pemetrexed, Radiotherapy)

        Recruiting
        • Leptomeningeal Metastasis
        • Changchun, Jilin, China
          The First Hospital of Jilin University
        Jun 8, 2022

        Tuberculosis, Meningeal Trial in Pune, Chennai, Lilongwe (High-dose: RIF, INH, PZA, EMB, High dose: RIF, INH, PZA, LEVO,

        Completed
        • Tuberculosis, Meningeal
        • High-dose: RIF, INH, PZA, EMB
        • +2 more
        • Pune, Maharashtra, India
        • +2 more
        Oct 27, 2021

        NSCLC, EGFR Activating Mutation, Brain Metastases Trial in Beijing (TY-9591 Tablets)

        Recruiting
        • NSCLC
        • +3 more
        • TY-9591 Tablets
        • Beijing, Beijing, China
          National Cancer Center/Cancer Hospitial,Chinese Academy of Medic
        May 14, 2022

        NSCLC, Brain Metastases, Leptomeningeal Metastasis Trial in Zhengzhou (almonertinib, LM-first line treatment, LM-second line

        Recruiting
        • NSCLC
        • +2 more
        • Zhengzhou, Henan, China
          Henan Cancer Hospital
        Aug 25, 2021